Minimal Residual Disease in NPM1-Mutated AML

被引：2
作者：
Burke, Michael J. [1 ,2 ]
机构：
[1] Med Coll Wisconsin, Dept Pediat, Div Hematol Oncol Blood & Marrow Transplantat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[2] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 05期
关键词：
ACUTE MYELOID-LEUKEMIA; CHILDRENS ONCOLOGY GROUP; RISK;
D O I：
10.1056/NEJMe1515525
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [31] Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens
    Lachowiez, Curtis A.
    Loghavi, Sanam
    Kadia, Tapan M.
    Daver, Naval
    Borthakur, Gautam
    Pemmaraju, Naveen
    Naqvi, Kiran
    Alvarado, Yesid
    Yilmaz, Musa
    Short, Nicholas
    Ohanian, Maro
    Pierce, Sherry R.
    Patel, Keyur P.
    Qiao, Wei
    Ning, Jing
    Sasaki, Koji
    Takahashi, Koichi
    Jabbour, Elias
    Andreeff, Michael
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Konopleva, Marina
    DiNardo, Courtney D.
    [J]. BLOOD ADVANCES, 2020, 4 (07) : 1311 - 1320
  • [32] Mutations highly speci fi c for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML
    Chan, Onyee
    Al Ali, Najla
    Tashkandi, Hammad
    Ellis, Austin
    Ball, Somedeb
    Grenet, Justin
    Hana, Caroline
    Deutsch, Yehuda
    Zhang, Ling
    Hussaini, Mohammad
    Song, Jinming
    Yun, Seongseok
    Talati, Chetasi
    Kuykendall, Andrew
    Padron, Eric
    Walker, Alison
    Roboz, Gail
    Desai, Pinkal
    Sallman, David
    Sweet, Kendra
    Komrokji, Rami
    Lancet, Jeffrey
    [J]. BLOOD ADVANCES, 2024, 8 (05) : 1075 - 1083
  • [33] Cluster Analysis Identifies a Specific Immunophenotypic Profile Associated with High Risk of Induction Failure and Shorter Survival in NPM1-Mutated AML
    Piccini, Matteo
    Bencini, Sara
    Francesco, Mannelli
    Gianfaldoni, Giacomo
    Scappini, Barbara
    Caporale, Roberto
    Peruzzi, Benedetta
    Annunziato, Francesco
    Bosi, Alberto
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S217 - S217
  • [34] NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1
    Zhao, Davidson
    Zarif, Mojgan
    Eladl, Entsar
    Capo-Chichi, Jose-Mario
    Smith, Adam C.
    Atenafu, Eshetu G.
    Tierens, Anne
    Minden, Mark D.
    Schuh, Andre
    Chang, Hong
    [J]. LEUKEMIA RESEARCH, 2022, 118
  • [35] Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation
    Braune, Jan
    Rieger, Kathrin
    Blau, Olga
    Keller, Ulrich
    Bullinger, Lars
    Kroenke, Jan
    [J]. CASE REPORTS IN HEMATOLOGY, 2022, 2022
  • [36] Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia
    Pettersson, Louise
    Johansson Alm, Sofie
    Almstedt, Alvar
    Chen, Yilun
    Orrsjo, Gustav
    Shah-Barkhordar, Giti
    Zhou, Li
    Kotarsky, Heike
    Vidovic, Karina
    Asp, Julia
    Lazarevic, Vladimir
    Saal, Lao H.
    Fogelstrand, Linda
    Ehinger, Mats
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : 664 - 674
  • [37] Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy
    Othman, Jad
    Tiong, Ing S.
    'Nions, Jenny
    Dennis, Mike
    Mokretar, Katya
    Ivey, Adam
    Austin, Michael
    Latif, Anne -Louise
    Amer, Mariam
    Chan, Wei Yee
    Crawley, Charles
    Crolla, Francesca
    Cross, Joe
    Dang, Ray
    Elliot, Johnathon
    Fong, Chun Y.
    Galli, So fia
    Gallipoli, Paolo
    Hogan, Francesca
    Kalkur, Pallavi
    Khan, Anjum
    Krishnamurthy, Pramila
    Laurie, John
    Loo, Sun
    Marshall, Scott
    Mehta, Priyanka
    Murthy, Vidhya
    Nagumantry, Sateesh
    Pillai, Srinivas
    Potter, Nicola
    Sellar, Rob
    Taylor, Tom
    Zhao, Rui
    Russell, Nigel H.
    Wei, Andrew H.
    Dillon, Richard
    [J]. BLOOD, 2024, 143 (04) : 336 - 341
  • [38] Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation
    Fraccaroli, Alessia
    Jurinovic, Vindi
    Hirschbuehl, Klaus
    Stauffer, Elena
    Koch, Katrin
    Breitkopf, Stephan
    Haebe, Sarah
    Drolle, Heidrun
    Rothenberg-Thurley, Maja
    Dufour, Annika
    Metzeler, Klaus H.
    Spiekermann, Karsten
    Hentrich, Marcus
    Hausmann, Andreas
    Verbeek, Mareike
    Schmid, Christoph
    Herold, Tobias
    Tischer, Johanna
    [J]. BLOOD ADVANCES, 2025, 9 (07) : 1630 - 1641
  • [39] Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia
    Patel, Jay L.
    Schumacher, Jonathan A.
    Frizzell, Kimberly
    Sorrells, Shelly
    Shen, Wei
    Clayton, Adam
    Jattani, Rakhi
    Kelley, Todd W.
    [J]. LEUKEMIA RESEARCH, 2017, 56 : 7 - 12
  • [40] The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations
    Tiacci, E.
    Spanhol-Rosseto, A.
    Martelli, M. P.
    Pasqualucci, L.
    Quentmeier, H.
    Grossmann, V.
    Drexler, H. G.
    Falini, B.
    [J]. LEUKEMIA, 2012, 26 (03) : 554 - 557
12345